Results 141 to 150 of about 828 (162)

O.7 Novel approach to sialic acid therapy in DMRV/hIBM mouse model

open access: closedNeuromuscular Disorders, 2010
May Christine V. Malicdan   +5 more
openalex   +2 more sources

T.O.1 Sialic acid metabolites preclude the development of myopathic phenotype in the DMRV/hIBM mouse model

open access: closedNeuromuscular Disorders, 2009
May Christine V. Malicdan   +4 more
openalex   +2 more sources

G.P.5.03 Genotype–phenotype correlation of DMRV/hIBM patient in Japan

open access: closedNeuromuscular Disorders, 2009
K. Momma   +6 more
openalex   +2 more sources

G.P.13.09 Proteomic analysis of distal myopathy with rimmed vacuoles (DMRV) or hereditary inclusion body myopathy (hIBM)

open access: closedNeuromuscular Disorders, 2007
May Christine V. Malicdan   +4 more
openalex   +2 more sources

GNE-myopathy (HIBM): Upper and lower extremity muscle strength declines over time in a prospective study

open access: closedNeuromuscular Disorders, 2017
Anthony Béhin   +9 more
openalex   +2 more sources

O.8 Treatment of hyposialylation in mouse model of DMRV/hIBM with novel synthetic sugar compounds

open access: closedNeuromuscular Disorders, 2010
Tomoharu Tokutomi   +5 more
openalex   +2 more sources

P4.46 Expression of human GNE through adeno-associated virus mediated therapy delays progression of myopathy in the DMRV/hIBM mouse model

open access: closedNeuromuscular Disorders, 2011
May Christine V. Malicdan   +11 more
openalex   +2 more sources

G.P.5.05 The evaluation of N-acetylmannosamine in model mouse towards the development of therapeutic strategy in DMRV/hIBM

open access: closedNeuromuscular Disorders, 2009
S. Noguchi   +4 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy